Below is Validea's guru fundamental report for PFIZER INC (PFE). Of the 22 guru strategies we follow, PFE rates highest using our Shareholder Yield Investor model based on the published strategy ...

Below is Validea's guru fundamental report for PFIZER INC (PFE). Of the 22 guru strategies we follow, PFE rates highest using our Shareholder Yield Investor model based on the published strategy ...

In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against the other pharma dividend stocks. The pharmaceutical industry in 2024 faced a relatively quiet year ...

We like to see robust dividend yields, but that doesn't matter if the payment isn't sustainable. Based on the last payment, the company wasn't making enough to cover what it was paying to ...

The first human bird flu death in the US has Moderna's vaccine development in focus for investors this week. Pfizer (PFE) reachead $26.91 at the closing of the latest trading day, reflecting a -0.83% ...

In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against the other healthcare stocks Jim Cramer has made bold predictions about. Healthcare has been one of Jim ...

Vous rejoignez l’ingénieur chargé de construction durable et de qualité environnementale qui a pour missions de développer la mise en œuvre du réemploi sur les projets, parfaire la gestion ...

In a report released today, Umer Raffat from Evercore ISI maintained a Buy rating on Pfizer (PFE – Research Report). The company’s shares closed yesterday at $25.57. Pick the best stocks and ...

Pfizer (NYSE:PFE) shares traded higher in the premarket on Tuesday after the New York-based pharma giant issued its full-year 2025 guidance and reaffirmed its full-year 2024 outlook in line with ...

Use a stop loss below $24 to manage risk, as PFE's current position offers a higher reward-to-risk ratio within the consolidation phase. Looking at Chart 1 above, you can see the blue arrow in ...